Stockscreener 앱 받기
16.18
0.86%
-0.14
시간 외 거래:
16.64
0.46
+2.84%
Ceribell Inc 주식(CBLL)의 최신 뉴스
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Receives FedRAMP® High Authorization, Expanding - GlobeNewswire
Ceribell announces EEG system received full RedRAMP High authorization - TipRanks
JPMorgan Chase & Co. Takes $880,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Geode Capital Management LLC Makes New $6.65 Million Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
CeriBell, Inc. to Release Q1 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq
CBLL Stock Sees Surge of Approximately 3.50% in Last Five Days - knoxdaily.com
Ceribell Inc (CBLL) stock analysis: A comprehensive overview - uspostnews.com
CeriBell (NASDAQ:CBLL) Trading Down 2.9% on Insider Selling - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - markets.businessinsider.com
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric - GlobeNewswire
Groundbreaking FDA Approval: Ceribell's AI Now Detects Seizures in Children Within Minutes - Stock Titan
Corebridge Financial Inc. Buys Shares of 6,122 CeriBell (NASDAQ:CBLL) - Defense World
Norges Bank Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell (NASDAQ:CBLL) Shares Gap Up – Still a Buy? - Defense World
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Ceribell braces for tariff impact on margins By Investing.com - Investing.com Canada
CeriBell's Stock Climbs As Tariff Relief Extends To 2025 - Finimize
Sector Update: Health Care - TradingView
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4 - MarketScreener
William Blair maintains Ceribell Outperform amid tariff concerns By Investing.com - Investing.com Canada
Canaccord maintains Ceribell stock buy rating, $33 target By Investing.com - Investing.com South Africa
William Blair maintains Ceribell Outperform amid tariff concerns - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
11.62%
0.20%
자본화:
|
볼륨(24시간):